What is Opus Genetics's non cash share issuances?

Opus Genetics (IRD) reported non cash share issuances of $14.25K in Q4 2025.

What does non cash share issuances mean?

Represents the value of equity instruments issued to settle obligations or acquire assets without a direct cash outlay. This metric is critical for evaluating dilution and the extent to which the company preserves cash by using stock as a form of payment. It provides insight into the company's strategy for managing liquidity during the clinical development phase.

Opus Genetics IRD Non Cash Share Issuances

Non Cash Share Issuances at other companies

KEE

Keel Infrastructure Corp. Common StockKEEL

$19.54M—

CleanSparkCLSK

$0—

Comstock Inc.LODE

$0-100%

MidCap Financial Investment CorporationMFIC

$110.04M—

KEE

Keel Infrastructure Corp. Common StockKEEL

$19.54M—

Watts Water Technologies, Inc.WTS

$400K-50.0%

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept ird:NonCashShareIssuances.

The official record: Opus Genetics’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's non cash share issuances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's non cash share issuances?: Opus Genetics (IRD) reported non cash share issuances of $14.25K in Q4 2025.
What does non cash share issuances mean?: Represents the value of equity instruments issued to settle obligations or acquire assets without a direct cash outlay. This metric is critical for evaluating dilution and the extent to which the company preserves cash by using stock as a form of payment. It provides insight into the company's strategy for managing liquidity during the clinical development phase.